Alpha-1-Antitrypsin Deficiency in Serbian Adults with Lung Diseases

2012
Authors
Topić, Aleksandra
Stankovic, Marija
Divac-Rankov, Aleksandra

Petrović-Stanojević, Nataša
Mitić-Milikić, Marija
Nagorni-Obradović, Ljudmila
Radojković, Dragica
Article (Published version)

Metadata
Show full item recordAbstract
Aim: Alpha-1-antitrypsin (A1AT) is the main inhibitor of neutrophil elastase, and severe alpha-1-antitrypsin deficiency (A1ATD) is a genetic risk factor for early-onset emphysema. Despite the relatively high prevalence of A1ATD, this condition is frequently underdiagnosed. Our aim was to determine the distribution of the A1ATD phenotypes/alleles in patients with lung diseases as well as in the Serbian population. Methods: The study included the adults with chronic obstructive pulmonary disease (COPD) (n = 348), asthma (n = 71), and bronchiectasis (n = 35); the control was 1435 healthy blood donors. The A1ATD variants were identified by isoelectric focusing or polymerase chain reaction-mediated site-directed mutagenesis. Results: PiMZ heterozygotes, PiZZ homozygotes, and Z allele carriers are associated with significantly higher risk of developing COPD than healthy individuals (odds ratios 3.43, 42.42, and 5.49 respectively). The calculated prevalence of PiZZ, PiMZ, and PiSZ was higher ...in patients with COPD (1:202, 1:8, and 1:1243) than in the Serbian population (1: 5519, 1: 38, and 1:5519). Conclusion: The high prevalence of A1ATD phenotypes/allele in our population has confirmed the necessity of screening for A1ATD in patients with COPD. On the other hand, on the basis of the estimated number of those with A1ATD among the COPD patients, it is possible to assess the diagnostic efficiency of A1ATD in the Serbian population.
Source:
Genetic Testing and Molecular Biomarkers, 2012, 16, 11, 1282-1286Publisher:
- Mary Ann Liebert Inc, New Rochelle
Projects:
DOI: 10.1089/gtmb.2012.0152
ISSN: 1945-0265
PubMed: 22971141